|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Received for publication, December 7, 1995, and in revised form, March 5, 1996)
From the Max Delbrueck Centrum for Molecular Medicine, 13125
Berlin-Buch, Germany, the § Institute of Bioorganic
Chemistry, Academy of Sciences of Belarus, 220141 Minsk, Belarus, and
the ¶ Institute for Technical Biochemistry, University of
Stuttgart, 70569 Stuttgart, Germany
Cardiolipin has been shown to be the most
effective activator of cholesterol side chain cleavage activity of
cytochrome P450SCC, and evidence has been provided for a lipid effector
site on the enzyme. Results suggested the headgroup of cardiolipin as
major determinant of lipid interaction with P450SCC (Lambeth, J. D.
(1981) J. Biol. Chem. 256, 4757-4762). The role of
unsaturation is contradictory and open to question (Igarashi, Y. and
Kimura, T. (1986) Biochemistry 25, 6461-6466). We
synthesized phosphatidylcholines with fully saturated branched fatty
acyl chains substituted in the 2-positions of the main chains and
studied the influence of these lipids on the activity and other
properties of P450SCC in vesicle-reconstituted systems.
These saturated branched lipids, with regard to the fatty acyl moiety
in molecular shape similar to cardiolipin but with the headgroup of
phosphatidylcholines retained, showed a stimulatory efficiency higher
than any other phospholipid and at least comparable to cardiolipin.
Activation is sensitive to the acyl chain structure and composition.
Results suggest that the shape of the molecule at least partially plays
an important role in the process of stimulation of the activity of
P450SCC. Because binding of cholesterol was increased by the branched
lipids monitored optically by the fraction of P450SCC in the high spin
form, it was concluded that these lipids, like cardiolipin and other
lipids, exert their effects by regulating the binding of cholesterol to
P450SCC. These data suggest that polymorphic lipids such as branched
phosphatidylcholines and cardiolipin might influence P450SCC function
by maintenance of the membrane curvature at a value optimal for
activity.
Cytochrome P450SCC (P450SCC),1 located
at the matrix side of the inner mitochondrial membrane in cells of the
adrenal cortex and other steroid-producing tissues catalyzes the side
chain cleavage (SCC) of cholesterol to yield pregnenolone, the common
precursor of all steroid hormones. Cholesterol SCC activity of P450SCC
can be reconstituted in phospholipid vesicles whereby the activity was
found to be dependent on lipid constituents used, the method of
reconstitution, and the size of the vesicles (for a review see Ref. 1,
and citations therein). P450SCC systems appear to exhibit specific
lipid-protein interactions. It was found that some lipids exert their
stimulatory effect by increasing the interaction between cholesterol
and P450SCC. For instance, cardiolipin (to date the most potent
activator lipid) binds to the enzyme in a 1:1 complex, thereby
activating the enzyme by enhancing the binding of cholesterol (2).
The major determinant of the CL specificity is the headgroup (3), but
the fatty acyl chain composition also has large effects on activity (4,
5). In general, activity correlates with the degree of unsaturation,
but somehow contradictory observations were reported with certain PCs.
Saturated phospholipids exhibited an inhibition for steroidogenic
activity, and a particularly important role has been attributed to
certain polyunsaturated configurations, e.g. to the adrenoyl
(C22:4) group. Taken together, there is no doubt that both head and
fatty acid groups attribute to the stimulation, yet the relative
importance of both groups and perhaps other previously unconsidered
structural properties of the phospholipid molecules remain to be
solved.
Cardiolipin, while poor in (C22:4), appears exceptional in its
stimulatory efficiency. Moreover, being a potent activator of SCC
activity, it proved a potent inhibitor of another mitochondrial P450,
P45011[GenBank]
The present paper is aimed at the elucidation of the possible
importance of such a lipid configuration for the process of cholesterol
side chain cleavage activity of P450SCC. For this purpose, the
[14C]Cholesterol was from Amersham.
DOPC and DMPC were from Sigma, and bovine heart cardiolipin,
cholesterol, and glucose oxidase from Serva (Germany). Catalase was
from Merck (Darmstadt, Germany). The P450SCC, adrenodoxin (AD), and adrenodoxin reductase (AR) were purified
from bovine adrenocortical mitochondria to electrophoretic purity using
specific affinity adsorbents (8, 9). They were stored until use at
The two diacyl phosphatidylcholines
containing branched fatty acids, depicted in Fig. 1, were synthesized
according to the method of Hermetter and Paltauf (10) as described in
Ref. 7. Briefly, after activation by carbonyl diimidazole (11), crude
fatty acid imidazolide was used for the acylation of
sn-glycero-3-phosphocholines in the presence of sodium
methylsulfinylmethide as basic catalyst and tetramethylammonium
chloride for stabilization of the glycerophosphocholines in solution.
The crude reaction products were purified by silica gel chromatography,
and the purity was checked by thin layer chromatography and high
pressure liquid chromatography as described in Ref. 7.
The compounds were analyzed with fast atom bombardment-mass
spectrometry and 1H and 13C NMR and
characterized by NMR and Langmuir-Blodgett-monolayer investigations
(7). NMR revealed a different headgroup orientation as compared to PC,
with only two straight chains. LB-analysis showed larger lift-off areas
and tighter acyl-chain packing at the collapse point than DMPC.
Small unilamellar
vesicles (SUV) were prepared by ultrasonication as described previously
with small modifications (12, 13). 12 mg of the phospholipid(s) in
chloroform/methanol (2:1, v/v) were mixed with usually 6 mol% (of
total lipid) cholesterol including a small amount of
[14C]cholesterol in absolute ethanol in a test tube, and
solvents were evaporated under N2 and kept under vacuum for
4 h. After complete removal of the solvent 3 ml of standard buffer (20
mM Hepes, pH 7.3, 50 mM KCl, 0.1 mM
dithiothreitol) were added and vortexed for 2 min. The suspension was
sonicated to clarity by using an USD 20 Desintegrator
(Akademie-Werkstaetten für Forschungsbedarf, Berlin,
Germany) at 150-watt power setting (30 min with 1:1 cooling intervals
of 1 min, under a gentle stream of N2) with the tubes
immersed in a water bath at 25 °C (DMPC) or at 0 °C (DOPC),
respectively. The resulting liposome suspension was chromatographed on
Sepharose 4B to separate the multilamellar vesicles and micellar lipid
aggregates from the SUVs (13). The size of the SUV was determined by
electron microscopy to be about 42 nm in diameter.
Reconstitution of P450SCC into the preformed vesicles was done
according to Refs. 5 and 14 by incubation of the SUV (600
µM final concentration) with P450SCC (1 µM
final concentration), or at any other desired lipid/protein ratio,
except that the incubation was done for 5 min at 37 °C. Successful
and almost complete incorporation of the P450SCC up to lipid/protein
ratios of about 5:1 (w/w) could be detected by gel chromatography using
Sepharose 4B or Sephacryl S-1000 (Pharmacia, Sweden) (not shown).
Activity of P450SCC was determined
as side chain cleavage activity of cholesterol to produce pregnenolone
according to the following assay; 0.25 µM P450SCC and 7
µM AD in standard buffer were incubated at 37 °C for
10 min with vesicles consisting of 400 µM phospholipid
with 6 mol% cholesterol including [14C]cholesterol in a
total volume of 0.5 ml. 0.25 µM AR was added, and the
reaction was initiated by addition of 2.5 mM NADPH (to
final concentration of 250 µM). After 5 min the reaction
was terminated by addition of 0.1 ml of 0.5 N HCl. The
residual substrate and the product were extracted with 2 × 2 ml of
methylene chloride, and pregnenolone was separated from unreacted
cholesterol by thin layer chromatograpy on silica gel (0.25 mm, 20 ×
20 cm; Merck, Darmstadt, Germany) using a solvent mixture of
n-hexane/petroleum ether/acetic acid (15:15:1, v/v/v).
Analysis was done by counting the 14C radioactivity of
cholesterol and pregnenolone using a Linear Analyzer LB284 (Berthold,
Wildbad, Germany). Each analysis was done three times to ensure
reproducibility within a standard error of about less than 7%.
Stopped-flow
experiments to monitor the transfer of the first electron from AD to
P450SCC were conducted at 21 °C using a computer-controlled
sequential stopped-flow ASVD Spectrofluorimeter DX-17 MV (Applied
Photophysics, Leatherhead, United Kingdom). For stopped-flow
measurements, solution A in syringe A contained 1 µM
P450SCC, 1200 µM phospholipid(s), 6 mol% cholesterol in
standard buffer. Syringe B contained 1 µM AR, 15
µM AD, and 2.5 mM NADPH in the same buffer.
An oxygen-consuming system consisting of 50 units/ml glucose oxidase,
10000 units/ml catalase, and 100 mM glucose was added to
both mixtures, which were then treated with CO for 10 min at room
temperature just before the measurement. Reduction of P450SCC was
followed by monitoring the absorbance increase at 450 nm caused by the
reduced P450SCC-CO complex. Rate constants and the extent of reduction
were obtained by exponential fits of the experimental data using the
software provided with the fluorimeter.
The concentration of P450SCC was
determined from reduced CO minus reduced difference spectra using a
difference extinction coefficient of 91 mM Phospholipid phosphorus was determined by the method of Ames and Dubin
(17). The ashing was performed according to the method of Hess and Derr
(18). Briefly, samples containing lipid (200 µl) were dried down in
glass tubes and 30 µl of 10 N
H2SO4 and 90 µl of 60% perchloric acid were
added. The tubes were heated to 190 °C until the samples stopped
fuming. Water (0.9 ml) was added, followed by the addition of 2.1 ml of
0.42 M ammonium molybdate × 4H2O in 1
N H2SO4/10% ascorbic acid (6:1
mixture). The solutions were incubated at 45 °C for 30 min, and the
absorbance at 660 nm was determined. A standard curve for calibration
was constructed by using inorganic phosphorus in the range of 0.1-10
mg.
Fig. 1 shows the chemical
structures of the 1,2-diacyl-sn-glycero-3-phosphocholines
containing hexyl and octyl substituents in the 2-position of their
decanoyl and dodecanoyl fatty acid chains, respectively (branched
1,2-diacyl PCs), used in the present studies. For comparison and
discussion of the results the molecular structure of CL was included in
the scheme, too. Mitochondrial CL represents a heterogeneous mixture
with regard to the fatty acyl chain composition; here we show a CL
molecule with two 18:2 acyl chains, which compromise the most abundant
fatty acid component of bovine heart mitochondrial CL (4).
According to their effects on the catalytic activity of P450SCC, lipids
have been divided into two groups: lipids that activate the SCC
activity of P450SCC (activator lipids) and nonactivator lipids (5). PCs
containing saturated fatty acid chains (in particular DMPC) belong to
the nonactivator lipids and have been often used as ``host lipids''
in the construction of proteoliposomes to study the influence of
activator lipids on the rate of side chain cleavage by P450SCC (1, 19,
20). To facilitate direct comparison of our results with those
mentioned, we studied PC vesicles made from mixtures of activator
phospholipids (the branched 1,2-diacyl PCs) and a nonactivator lipid
(DMPC). In all experiments the cholesterol concentration of the vesicle
membranes constituted 6 mol% of total phospholipid, which
approximately corresponds to its content in the membrane of
mitochondria (21).
Fig. 2 shows the activity of P450SCC in vesicle
preparations containing pure DMPC and mixtures of DMPC with either
PC(10,6) or PC(12,8), respectively. The results demonstrate the effect
of varying the membrane content of the branched 1,2-diacyl PC. In each
case the total phospholipid content remained the same. To facilitate
direct comparison with previous experimental data, results were
normalized to 100% maximum activity corresponding to the region in the
activity plot where the activity reaches a plateau. Note that the 100%
value corresponds to 3.7 nmol of PG/min/nmol of P450SCC for PC(10,6)
and 3.9 nmol of PG/min/nmol of P450SCC for PC(12,8), respectively. As
can be seen from Fig. 2, inclusion of the branched PCs in the DMPC
vesicles results in a more than 6-fold enhancement of the SCC activity
of P450SCC. As the ratio of activator to nonactivator lipid is
increased, activity increases strongly until it reaches a plateau
value. It can clearly be seen that the activity curves have a sigmoidal
shape, in contrast to results obtained with CL as activator lipid using
the same vesicle system (2). Comparing the two branched PCs, we see
that the activity is sensitive to the acyl chain structure. As the
length of the acyl chains and the branched chains increase, a smaller
amount of PC(12,8) as compared to PC(10,6) is required for reaching the
limiting (plateau) value.
The activator capability of PC(10,6) and PC(12,8) can be quantitatively
compared to each other and to results obtained earlier by other groups
using their K1/2 values2
for half-maximum activation.
K1/2 values are not equal for both 1,2-diacyl
PCs. On a weight basis activation by the branched PC with the shorter
acyl chain, the half-maximal value is shifted toward a higher content
of the activator lipid. Table I summarizes the values
obtained; stimulation of activity is half-maximal when about 12.5
(13.9) weight % of the membrane phospholipid is branched 1,2-diacyl
PC. Taking into account the differences in the molecular weights of the
both branched PCs, the observed chain dependence of the activating
efficiency for the both branched PCs is even more significant; 10.6
mol% of PC(12,8) are required to half-maximum activation, compared to
13.4 mol% for PC(10,6). Compared to other activator lipids, the
branched PCs used in the present study are even more effective
stimulators of the SCC activity of P450SCC; moreover, they show
stimulation even higher compared to CL from beef heart and comparable
with the activation by CL from bacteria reported by Lambeth (1981). To
study the chain dependence in greater detail, it would be interesting
to use branched PCs with even longer acyl chain substituents in the
2-position; such experiments are now under way.
Half-maximum activation of SCC activity of P450SCC by branched
1,2-diacyl PCs and other activator lipids in DMPC vesicles
Recently,
for investigation of various aspects of P450SCC-lipid interaction,
vesicles made on the basis of DOPC were often used; applying these a
rather high rate of enzymatic activity as compared to DMPC could be
observed (1, 19, 22). Thus, it may be of interest to see to what extent
Fig. 3. Effect of branched 1,2-diacyl phosphatidylcholines on the SCC activity and the rate of reduction of P450SCC by NADPH in DOPC vesicles. In each case the vesicles contained 6 mol% cholesterol and the same amount of total phospholipid. P450SCC was reconstituted into the DOPC vesicles (see ``Experimental Procedures'') containing either 0% (left bar), 33 weight % PC(10,6) (middle), or 33 weight % PC(12,8) (right), respectively. Fig. 4. Effect of branched 1,2-diacyl phosphatidylcholines on the absorption spectra of P450SCC in DOPC vesicles. In each case the vesicles contained 6 mol% cholesterol and the same amount of total phospholipid. P450SCC was reconstituted into the DOPC vesicles (see ``Experimental Procedures'') containing either 0 ( ![]() ), 33 weight % PC(10,6) (- - -), or 33 weight %
PC(12,8) (···), respectively. Spectra were recorded with water in
the reference cuvette.
The kinetics of reduction of P450SCC in DOPC vesicles and its mixtures
with PC(10,6) and PC(12,8), respectively, was measured under conditions
in which reduced AD, together with its reducing equivalents and AR,
were mixed with P450SCC vesicles as described under ``Experimental
Procedures.'' In all systems studied the reaction could be
characterized by two phases, a fast and a slow phase, respectively. The
amount of P450SCC reduced within the fast phase of the reaction
accounts to about 52-57% and scarcely depended on the lipid
composition. The values of the rate of fast phase are shown in Fig. 3,
together with the corresponding enzymatic activities. Obviously,
inclusion of the Pember et al. (3) proved that the stimulation of the SCC activity of P450SCC by various PCs and CL is correlated with the fraction of P450SCC in the high spin state, reflecting a stronger binding of the substrate cholesterol to the enzyme. Based on absorption spectra, we found that the branched 1,2-diacyl PCs showed a similar effect (Fig. 4). In (pure) DOPC vesicles P450SCC was only 30% high spin; on the other hand, the high spin content was enhanced to about 84% and 82% when the vesicles contained 33 weight % PC(10,6) and PC(12,8), respectively. The increased high spin forms of P450 were observed only in vesicles containing (equally) 6 mol% cholesterol. Measurements were made with water in the reference cuvette. Thus, although both cholesterol and the total lipid content were kept equally, in each case the absorbance was different, probably caused by differences in the average size and degree of aggregation of the vesicles in the various vesicle suspensions. In conclusion, the optical spectra indicate that the branched PCs probably realize their stimulatory role on the SCC activity of P450SCC, like other activator lipids, via increasing the cholesterol binding to the enzyme, too. Temperature Dependence of the Catalytic Activity of P450SCC in Vesicles Consisting of Mixtures of DOPC and Branched 1,2-Diacyl PCsThe reaction of cholesterol conversion to pregnenolone in
P450SCC reconstituted into DOPC vesicles containing 33 weight %
PC(10,6) or PC(12,8) have been studied within the temperature range
15-42 °C. Fig. 5 demonstrates the effects of
temperature on the SCC activity of P450SCC; it can clearly be seen from
the data presented that, in the whole temperature region investigated,
the rate of pregnenolone formation is much higher for DOPC vesicles
containing 33 weight % of PC(10,6) and PC(12,8) as compared to (pure)
DOPC vesicles. All Arrhenius plots are characterized by breaks at
temperatures localized in the region of 27-30 °C. Obviously, the
existence of the break is determined by properties of the protein
component in the system, since it is well known that at least DOPC does
not undergo any phase changes in this physiological temperature
region.
Fig. 5. Arrhenius plots of the temperature dependence of cytochrome P450SCC activity in DOPC vesicles. Vesicle preparation as in legend of Fig. 3. Inset, activation energies and temperature of break points in the log V plots of the various DOPC vesicle systems. Straight lines represent least squares linear fits to the experimental points.
The value of activation energy Ea1 of the enzymatic process of cholesterol conversion to pregnenolone in DOPC liposomes could be determined in the region below the break temperature to about 11.9 kcal/mol and thus is compatible with values known for a number of other membrane-bound enzymatic systems (23). In contrast, a value of nearly zero observed for Ea2 above the break temperature is unusual and requires further and more detailed experiments for its interpretation. In general, it is clear that at least at the weight ratio of 1:2 inclusion of the branched PCs into the membrane of DOPC is not accompanied by essential changes in the activation energy. However, the Ea1 value in the mixture of DOPC and PC(10,6) in the region below the temperature break is somewhat decreased and becomes about 8 kcal/mol. In the presence of PC(12,8), Ea2 in the temperature region above the break point increases to about 1.6 kcal/mol. We found a very large difference in the activation energy and the temperature break point in the SCC reaction catalyzed by P450SCC for the branched PCs in DOPC compared to results reported for CL in DOPC vesicles (24). Decrease of the activation energy by 2 times and the observed shift of the break temperature by 7-10 °C toward lower temperatures in the presence of the branched PCs might be indicative of the formation of a rather ``less rigid'' protein-lipid configuration in the case of branched PC-containing DOPC vesicles. The ability to reconstitute P450SCC into phospholipid vesicles has provided an excellent system for studying the effects of lipids on the structure and function of this membrane enzyme which is a key enzyme in the mitochondrial steroidogenic apparatus (see Ref. 1, and citations therein). In relation to the present studies, it has been demonstrated previously by several classic papers that the stimulation of the activity was found to be due to an increased binding of cholesterol to the enzyme, i.e. activation is correlated with the fraction of P450SCC in the high spin form (2, 3, 4, 5, 6, 14, 24). Particularly for the specific mitochondrial phospholipid CL, which was most effective in stimulating both activity and spin state conversion when compared to other lipids, stimulation of cholesterol binding to P450SCC was interpreted by direct binding of 1-2 molecules of CL to effector site(s) of the enzyme to provide the P450SCC with optimal activity whereby the headgroup of the phospholipid appears as major determinant of the lipid interaction with P450SCC (2, 3, 5). While the high specificity of the CL-P450SCC interaction has clearly
been shown, until now the importance of unsaturation of the fatty acid
components of phospholipids including CL could not unambiguously be
demonstrated. As discussed below, the results are contradictory. To
contribute for better understanding of specific lipid-protein
interactions and the role that different structural moieties of lipids,
particularly CL, might play in the stimulation of SCC activity of
P450SCC, we synthesized two derivative phosphatidylcholines with fully
saturated The stimulation of the SCC activity by the saturated branched PCs
accounts to more than a factor of 6. For comparison, it should be
mentioned that under similar conditions with regard to cholesterol
content, protein-protein and protein/lipid relationship, ionic
strength, lipid composition, and pH of buffer, the catalytic activity
of P450SCC was increased by bovine adrenal cortex CL by 4-5 times
(20). In Ref. 2, absolute values for the activity in DMPC vesicles
containing CL from various sources were not reported, making comparison
based on absolute activities difficult. However, for comparison,
quantitation of the stimulatory efficiency of different PCs is possible
based on the K1/2 values for half-maximum
stimulation. Comparing the data in Table I and taking into account the
2-fold increase of the reaction rate after inclusion of PC(10,6) or
PC(12,8) in DOPC vesicles (see Fig. 3) leaves no doubt that the
effectiveness of stimulation of the P450SCC activity by saturated
To facilitate quantitative comparison to previous results, we analyzed the action of the activator lipids by the same equilibrium model according to which the binding of n activator lipids molecules to effector site(s) on P450SCC influences the activity (for further discussion, see Refs. 1 and 2). Nevertheless, it should be noted that other mechanisms might exist as interpretation, for instance specific lipid-lipid interactions, cholesterol-lipid interactions, local nonbilayer phases, etc. In the present paper, vesicles were prepared from mixtures of a nonactivator (host) lipid (DMPC) and an activator lipid (branched 1,2-diacyl PC). Fig. 2 shows the experimental and theoretical activity data. As can be seen, the experimental data for both branched 1,2-diacyl PC systems could be satisfactorily fitted to the n = 3 and 4 sigmoidal theoretical curves. n = 1 corresponds to a hyperbolic dependence not observed experimentally for the both branched PCs under investigation. This is in strict contrast to CL, for which a hyperbolic dependence was reported. The best fit for PC(10,6) was reached with n = 3; for PC(12,8), n = 4 gave the best fit; other exponents led to less good fits (not shown). How do the As follows from the stopped-flow kinetics experiments, in the presence
of branched PCs a ~2-fold increased rate of electron transfer to
P450SCC could be observed. However, the relative high value of this
rate both in the absence (3.3 s According to Refs. 3 and 5, one can consider three general classes of
mechanism by which fatty acyl moieties of phospholipids might affect
the binding of cholesterol to P450SCC. First, some physical property of
the lipid phase or the membrane, e.g. fluidity, nonbilayer
phase, or phase transition temperature of the lipid, regulates the
activity of P450SCC. Because we have until now investigated only
mixtures and not the pure lipid system, it is not possible to consider
this possibility decisively. The second mechanism assumes for each
lipid a given affinity for cholesterol competing with P450SCC for
cholesterol binding; this possibility was excluded because the order of
affinity of various lipids for cholesterol is not correlated inversely
with the affinity of P450SCC for cholesterol (for further discussion
see Ref. 5). A third possibility, that the cholesterol binding is
regulated by direct interaction of the lipid(s) with the P450SCC, seems
most consistent with the new data obtained by studying the effect of
branched PCs on the activity of P450SCC. 1-2 molecules of CL or 3-4
branched PCs, respectively, bind highly specific to P450SCC at an
effector site distant from the cholesterol binding site with a
resultant stabilization of an optimal cholesterol-binding conformation
of P450SCC. Although it is possible to consider such an explanation for
the interpretation of our results, too, we believe that another model
than the specific allosteric binding model is more consistent with the
available data. Remembering the structural similarity of the
hydrophobic region of the branched PCs and CL, we propose that the
molecular shape of the lipid molecule may be a partial determinant for
the interaction between P450SCC and lipids. Both CL as well as the
branched PCs belong to a class of lipids (so-called polymorphic lipids)
that have a great tendency to adopt nonbilayer structures under certain
conditions (25, 26, 27). Currently there is a considerable experimental
effort and discussion about the possible functions of polymorphic
lipids in biological membranes. For example, Gruner (28) and Hui and
Sen (29) have suggested that curvature strain by polymorphic lipids may
modulate the activity of some membrane proteins. Following such a
hypothesis, one can suppose that some polymorphic lipids are necessary
to accommodate the P450SCC in an optimal conformation to the bilayer.
Such a model is supported by the finding that the incorporation of
P450SCC into octylglucoside-reconstituted (relatively large) PC/PE/CL
vesicles and its mobility in the membrane depend critically on the CL
content of the membrane (30). Furthermore, it has been reported
previously that reconstitution by both octylglucoside and cholate
dialysis results in the formation of two main populations of vesicles,
larger and smaller ones with the smaller vesicles containing
significantly more P450SCC (31, 32). Recently it was reported that the
size of the vesicles, which in turn determines the vesicle curvature,
has a large influence on the activity (22). Taken together, these
findings all suggest that the curvature of the membrane plays a role
for the incorporation of P450SCC and thus support our view that
polymorphic lipids like CL and the branched PCs could influence P450SCC
by maintenance of the membrane curvature at a value optimal for P450SCC
activity. It is too early to speculate on the possible physiological
relevance of these results. However, it should be mentioned that PE
also is a lipid which is able to adopt nonbilayer phases (27) and that
PE together with CL comprise Our results are not in accordance with conclusions on the importance of unsaturated fatty acid groups of phospholipids with regard to their steroidogenic activity. In Ref. 4, a strong correlation of the SCC activity of P450SCC with the degree of unsaturation in the fatty acid moiety, regardless of headgroup, was reported. Moreover, saturated phospholipids exhibited inhibition of steroidogenic activity. No such simple relation between the degree of chain unsaturation and activity was reported in Ref. 5, but generally the activity was found relative low in saturated PCs. Our results clearly show that the inhibition of stimulation is not related to saturation of the fatty acid components. As shown, fully saturated PCs as the branched PCs used lead to a very high stimulation. Taking into account the roughly comparable stimulation by predominantly saturated bacterial and unsaturated bovine CL, respectively (2), and our results, it seems that unsaturation of the fatty acyl chain region is of less importance. The sometimes higher activity found for several unsaturated PCs, which did not correlate with the number of double bonds in the various chains, also might be indicative of a decisive role of the lipid conformation in connection with a higher propensity of these lipids to adopt nonbilayer phases. This is supported by a significant promotion of hexagonal phase formation of fatty acid-PE mixtures by increasing unsaturation of fatty acids reported recently (33). In conclusion, by application of the branched 1,2-diacyl PCs, it was possible to provide for the first time direct evidence for a specific lipid-P450SCC interaction with an apparently important role of the saturated hydrophobic fatty acyl chain region of the lipid. The results suggest polymorphic lipids as CL and branched PCs might be important in control of P450SCC activity. Finally, our data highlight the potential usefulness of P450SCC vesicles containing branched 1,2-diacyl PCs in studies of the effect of polymorphic lipids on the biological activity of membrane-bound enzymes. * This study was supported by Grants Schw 471/1-3 and 436 WER 17/6/94 S from the German Research Foundation (to D. S. and P. K.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Max Delbrueck Center
for Molecular Medicine, Robert Roessle Str. 10, 13125 Berlin-Buch,
Germany. Tel.: 49-30-9406-3743; Fax: 49-30-949-4161; E-mail:
schwarz{at}orion.rz.mdc-berlin.de.
1 The abbreviations used are: P450SCC, cytochrome P450SCC (CYP11A1); AD, adrenodoxin; AR, adrenodoxin reductase; SCC, side chain cleavage; PC, phosphatidylcholine; CL, cardiolipin; PG, pregnenolone; 1,2-diacyl PCs: PC(10,6), 1,2-di-[(2 -hexyl)decanoyl]-PC; PC(12,8),
1,2-di-[(2 -octyl)dodecanoyl]-PC; DMPC, dimyristoyl-PC; DOPC,
dioleoyl-PC.
2 K1/2 values are expressed as the weight ratio of activator lipid (branched 1,2-diacyl-PC) to total phospholipid (including cholesterol) required to half-maximum stimulation of the SCC activity, where the maximal velocity was taken in our case as the rate obtained from the plateau value extrapolated to infinite activator lipid concentration. We thank Dr. Rudolph (University of Potsdam,
Germany) for electron microscopic characterization of the vesicle
suspensions. We acknowledge the gift of the
©1996 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||